This year, the Michigan Value Collaborative (MVC) completed scoring and evaluation for Program Year (PY) 2025 of the MVC Component of the Blue Cross Blue Shield of Michigan (BCBSM) Pay-for-Performance (P4P) Program. This concluded a two-year program cycle encompassing the program methodologies and conditions utilized in PYs 2024 and 2025. MVC recently completed an evaluation of these two program years, which focused on hospital performance on average 30-day risk-adjusted, price-standardized total episode payments for the included conditions as well as utilization rates for the included value metrics across both program years.
The PY 2024-2025 program cycle utilized episode claims from 2021 through 2024. PY 2024 scoring compared performance year data from 2023 against baseline year data from 2021. PY 2025 scoring compared performance year data from 2024 against baseline year data from 2022.
Hospitals chose one episode spending condition from six available options for the PY 2024-2025 program cycle, including chronic obstructive pulmonary disease (COPD), colectomy (non-cancer), congestive heart failure (CHF), coronary artery bypass graft (CABG), joint replacement (hip and knee), and pneumonia. Among these six P4P conditions, joint replacement was the most selected condition (31), and pneumonia was the least frequently selected (6). Colectomy was not selected by any hospital.
Trends in average price-standardized episode payments showed a consistent decrease over the years for joint replacement. Both COPD and CABG showed relatively consistent trend in payments and had the highest payments in 2022 as seen in Figure 1. Both PYs saw an average decrease in payments in both CABG and joint replacement. Joint replacement was the largest contributor to the cost savings in this cycle with a decrease of $3 million dollars in PY 2024 and $1.9 million dollars in PY 2025.
Figure 1. Average Price-Standardized Episode Payment Trends for P4P Conditions (2020-2024)
MVC further assessed the components contributing to total episode spending, and determined all conditions except COPD showed a decrease in spending in at least one episode component (i.e., index payment, professional services, post-discharge care, readmissions) across both PYs (Figures 2-3). Joint replacement showed decreased spending across all components in PY 2025 and across all components except readmissions in PY 2024. Similarly, all conditions demonstrated a reduction in spending for at least one post-discharge component in both PYs. Home health spending decreased across all conditions while inpatient rehabilitation spending increased for most conditions in both PYs. Emergency department spending also decreased for most conditions across both PYs.
Figure 2. Change in Average Price-Standardized Episode Components, PY 2024
Figure 3. Change in Average Price-Standardized Episode Components, PY 2025
In addition to selecting an episode spending condition, hospitals also selected one of seven available value metrics for the PY 2024-2025 program cycle. This included 7-day follow-up after CHF, 7-day follow-up after pneumonia, 14-day follow-up after COPD, 30-day inpatient readmissions after sepsis, 90-day cardiac rehab after CABG, 90-day cardiac rehab after PCI, and preoperative testing before low-risk surgeries (i.e., inguinal hernia repair, cholecystectomy, and lumpectomy). The 7-day follow-up after CHF metric (23) was the most frequently selected value metric followed by 90-day cardiac rehab after PCI (17). In contrast, 90-day cardiac rehab after CABG and 30-day inpatient readmissions after sepsis were the least frequently selected (5) value metrics.
Among the high-value metrics, hospitals that selected 14-day follow-up after COPD and 90-day cardiac rehab after PCI increased their utilization rate by 1.4% and 3.1%, respectively, from 2021 to 2023 (Table 1). In PY 2025, the utilization of 90-day cardiac rehab after CABG increased by 3.6% in 2024 compared to 2022 (Table 2). Among the low-value metrics, sepsis readmission rates decreased by 0.5% in PY 2024 and 7.0% in PY 2025. Preoperative testing rates decreased by 5% from 2022 to 2024 in PY 2025.
Table 1. Average Utilization Changes for P4P Value Metrics in PY 2024
Table 2. Average Utilization Changes for P4P Value Metrics in PY 2025
Overall, the average total points earned remained relatively stable between PY 2024 (6.6) and PY 2025 (6.7), as shown in Figure 4. Average episode spending points decreased from 2.4 to 2.2, while average value metric points increased from 2.4 to 2.6, and average engagement points increased from 1.7 to 1.8 from PY 24 to PY 25.
Figure 4. Average Points Earned by Scoring Components in PYs 2024-2025
The distribution of total points earned by participating hospitals in PY 2024 and PY 2025 are shown in Figures 5 and 6, respectively. Approximately 15% of hospitals scored the maximum score of 10 points in PY 2024 and this proportion decreased to 10% in PY 2025.
Figure 5. Distribution of Hospital Total Points Scored for PY 2024
Figure 6. Distribution of Hospital Total Points Scored for PY 2025
Additional details are contained in the full report. Please contact the Coordinating Center for more details on the report or for any questions regarding the PY 2024-2025 cycle.
